ESTRO PT 2018

Results in H&N Tumors

Meta-Analysis of Chemotherapy in Head&Neck Cancer - MACHNC

100

80

Loco-regional

63.2 %

RT

60

HR: 0.66

RT + concomitant 5-FU / platin

50.2 %

40

Distant

18.9 %

Risk of failure (%)

20

MACH-NC

16 %

Meta-Analysis of Chemotherapy in Head & Neck Cancer

0

Pignon JP et al 2009

0 1 2 3 4 5 6 7

 8

Time from randomisation (years)